Fanni Li

1.1k total citations
39 papers, 871 citations indexed

About

Fanni Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fanni Li has authored 39 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Fanni Li's work include Ferroptosis and cancer prognosis (6 papers), RNA modifications and cancer (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Fanni Li is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), RNA modifications and cancer (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Fanni Li collaborates with scholars based in China, United States and Canada. Fanni Li's co-authors include Qi Sun, Xiwen Dong, Qinglong Guo, Na Lu, Jian‐Li Jiang, Lin Peng, Fengkai Sun, Qidong You, Zhiyu Li and Xianghui Fu and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Small.

In The Last Decade

Fanni Li

37 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanni Li China 17 448 196 157 141 133 39 871
Qi You China 18 325 0.7× 211 1.1× 122 0.8× 157 1.1× 96 0.7× 51 939
Shakti Ranjan Satapathy India 22 606 1.4× 285 1.5× 141 0.9× 99 0.7× 82 0.6× 45 1.2k
Jing Ni China 19 654 1.5× 165 0.8× 422 2.7× 134 1.0× 92 0.7× 66 1.2k
Shun Tang China 10 520 1.2× 191 1.0× 171 1.1× 71 0.5× 67 0.5× 13 884
Li Lai United States 18 721 1.6× 217 1.1× 212 1.4× 98 0.7× 53 0.4× 43 1.2k
Shengyou Liao China 14 673 1.5× 111 0.6× 230 1.5× 98 0.7× 60 0.5× 32 1.0k
Alok Ranjan United States 18 610 1.4× 242 1.2× 221 1.4× 70 0.5× 47 0.4× 38 1.1k
Guihua Jin China 17 429 1.0× 176 0.9× 166 1.1× 248 1.8× 46 0.3× 35 937

Countries citing papers authored by Fanni Li

Since Specialization
Citations

This map shows the geographic impact of Fanni Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanni Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanni Li more than expected).

Fields of papers citing papers by Fanni Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanni Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanni Li. The network helps show where Fanni Li may publish in the future.

Co-authorship network of co-authors of Fanni Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fanni Li. A scholar is included among the top collaborators of Fanni Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanni Li. Fanni Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiawei, Zihan Qiu, Yue Han, et al.. (2025). ADAM17 Supports Disinhibition of Pre-sympathetic Glutamatergic Neurons Through Microglial Chemotaxis. Neuroscience Bulletin. 42(1). 189–209.
2.
Xu, Yuhang, Xiaoyu Xu, Yuan Zhao, et al.. (2025). A self-powered casein hydrogel E-dressing with synergistic photothermal therapy, electrical stimulation, and antibacterial effects for chronic wound management. Acta Biomaterialia. 198. 63–84. 12 indexed citations
3.
Hang, Peng, Zhenghui Li, Jiarui Xu, et al.. (2024). Comprehensive analysis reveals TSPEAR as a prognostic biomarker in colorectal cancer. Journal of Cancer. 15(3). 809–824.
4.
Sun, Qi, et al.. (2023). Development of fatty acid metabolism score based on gene signature for predicting prognosis and immunotherapy response in colon cancer. Clinical & Translational Oncology. 26(3). 630–643. 1 indexed citations
5.
Liu, Chang, Zhihua Lü, Jun Yan, et al.. (2023). Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer. Frontiers in Oncology. 13. 1234045–1234045. 5 indexed citations
6.
Sun, Qi, Jiawei Wang, Fanni Li, et al.. (2022). AT1 Receptors: Their Actions from Hypertension to Cognitive Impairment. Cardiovascular Toxicology. 22(4). 311–325. 20 indexed citations
7.
Wang, Yidian, Qian‐Cheng Luo, Yuan‐Qi Zhai, et al.. (2022). Heteroleptic Dysprosium(III) Single-Molecule Magnets with Amidinate and Cyclopentadienyl Ligands. Crystal Growth & Design. 22(11). 6398–6404. 12 indexed citations
8.
Luo, Qian‐Cheng, Yuan‐Qi Zhai, Lin Sun, et al.. (2022). A C,S bonded quasi-two-coordinate chromium(ii) complex showing field-induced slow magnetic relaxation behaviour. Dalton Transactions. 51(24). 9218–9222. 7 indexed citations
9.
Hang, Peng, Wan Zhang, Yankun Li, et al.. (2022). CircFAT1 Promotes Lung Adenocarcinoma Progression by Sequestering miR-7 from Repressing IRS2-ERK-mediated CCND1 Expression. International Journal of Biological Sciences. 18(10). 3944–3960. 4 indexed citations
10.
Li, Fanni, et al.. (2021). Development of a novel autophagy-related gene prognostic signature for gastric cancer. Translational Cancer Research. 10(6). 2790–2800. 4 indexed citations
11.
Sun, Qi, et al.. (2020). Interleukin-6 Promotes Epithelial-Mesenchymal Transition and Cell Invasion through Integrin β6 Upregulation in Colorectal Cancer. Oxidative Medicine and Cellular Longevity. 2020. 1–13. 36 indexed citations
12.
Li, Fanni, Feiyu Shi, Lei Zhang, et al.. (2020). <p>Expression of Integrin β6 and HAX-1 Correlates with Aggressive Features and Poor Prognosis in Esophageal Squamous Cell Carcinoma</p>. Cancer Management and Research. Volume 12. 9599–9608. 11 indexed citations
13.
Yan, Jin, Fanpu Ji, Siqi Yan, et al.. (2020). A general-purpose Nanohybrid fabricated by Polymeric Au(I)-peptide precursor to wake the function of Peptide Therapeutics. Theranostics. 10(19). 8513–8527. 34 indexed citations
14.
Sun, Qi, et al.. (2020). Integrin αvβ6 predicts poor prognosis and promotes resistance to cisplatin in hilar cholangiocarcinoma. Pathology - Research and Practice. 216(7). 153022–153022. 11 indexed citations
15.
Sun, Qi, et al.. (2018). Pontin Acts as a Potential Biomarker for Poor Clinical Outcome and Promotes Tumor Invasion in Hilar Cholangiocarcinoma. BioMed Research International. 2018. 1–9. 6 indexed citations
16.
Li, Fanni, Yi Zhang, Ze-Kun Liu, et al.. (2018). Systems analysis of key genes and pathways in the progression of hepatocellular carcinoma. Medicine. 97(23). e10892–e10892. 6 indexed citations
17.
Sun, Jie, Fanni Li, Yue Zhao, et al.. (2015). LZ-207, a Newly Synthesized Flavonoid, Induces Apoptosis and Suppresses Inflammation-Related Colon Cancer by Inhibiting the NF-κB Signaling Pathway. PLoS ONE. 10(5). e0127282–e0127282. 7 indexed citations
18.
Li, Chenglin, Fanni Li, Kai Zhao, et al.. (2014). LFG-500 Inhibits the Invasion of Cancer Cells via Down-Regulation of PI3K/AKT/NF-κB Signaling Pathway. PLoS ONE. 9(3). e91332–e91332. 31 indexed citations
20.
Lu, Na, Qi Qi, Fanni Li, et al.. (2011). Gambogic acid inhibits tumor cell adhesion by suppressing integrin β1 and membrane lipid rafts-associated integrin signaling pathway. Biochemical Pharmacology. 82(12). 1873–1883. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026